|
Patient
|
Gender
|
RETmutation
|
Age at diagnosis PHEO
|
Temporal relation of PHEO to MTC
|
NE/E/DA (ng/L)
|
Tumor (size, cm)
|
Operative procedure
|
Follow-up
|
|---|
|
F1-II4
|
F
|
C634F
|
26
|
Preceding
|
246.0/36.3/61.5
|
L, 3.3
|
Left OPE
|
163
|
|
F2-II1
|
M
|
C634Y
|
35
|
Concomitant
|
399.0/48.2/43.0
|
R, 2.5
|
Right OPE
|
74
|
|
F3-III7
|
F
|
C634Y
|
36
|
Preceding
|
827.5/106.0/88.5
|
R, 4.0
|
Right OPE
|
71
|
|
F4-II3
|
M
|
C634Y
|
47
|
Succeeding
|
657.0/144.2/40.0
|
L, 2.3
|
Left LPE
|
8
|
|
F5-II1
|
M
|
C634R
|
34
|
Succeeding
|
1305.0/1270.3/243.6
|
L, 10 ; R, 3.5
|
heterochronous bilateral OPE
|
252
|
|
F5-II7
|
M
|
C634R
|
47
|
Succeeding
|
667.7/92.5/78.3
|
R, 2.9
|
Right LPE
|
12
|
|
F6-III2
|
M
|
C634R
|
21
|
Concomitant
|
69.9/12.6/10.2
|
L, 3.5
|
Left LPE
|
24
|
|
F7-II2
|
F
|
C618R
|
40
|
Succeeding
|
681.2/89.4/67.0
|
L, 2.9
|
Left LPE
|
102
|
- Note: OPE, open PHEO excision; LPE, laparoscopic PHEO excision; NE (norepinephrine): normal, 0 ~ 600 ng/L; E (epinephrine): normal, 0 ~ 100 ng/L; DA(dopamine): normal, 0 ~ 100 ng/L.
